Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$TVRD

Tvardi Therapeutics, Inc. Common Stock

XNASHealth CarePharmaceutical Preparations

$1.87-6.54%$0.1307Prev $2.00LIVE Full chart Live alerts
No recent price bars, the chart lights up when TVRD starts printing.

Why is TVRD down today? It is at $1.87 (-6.54%), and our scanner flagged it 10 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment TVRD spikes, and full due diligence on TVRD — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $TVRD alerts the moment volume spikes

Our scanner flagged $TVRD 10 times in the last 30 days. Create a free account to track $TVRD, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$1.87
Change today
-6.54%
Previous close
$2.00
52-week range
$1.50 – $43.65
Valuation & dividend
Market cap
$19M
Ownership & volume
Insider ownership
7.9%
DEF 14A · 2026-04-23
Institutional own.
30.91%
Total held
38.8%
Tradeable float
5.7M
61% of shares · after 8% insiders + 31% institutions
Avg daily volume
687K
Next earnings
Aug 13 · in 7d
Classification
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
XNAS
Relative volumevs this time of day
5m
0.1x
15m
0.1x
1h
0.2x
1D
0.5x

Get free TVRD + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $TVRD down today?

Here is the latest on TVRD from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TVRD today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

Likely catalystTvardi Therapeutics Selects Ulcerative ColitisReported More than 70% of patients do not achieve clinicalReported up to 76% reduction in subsets associated with mucosal destruction and treatment-refractory UCReported up to 43% in Tfh subsets associated with disease UC activity, from the latest SEC filing. Read it →
Why is $TVRD moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profile📅 Earnings in 7dLow float · 5.7M shNot shortableNo SSRBorrow via Alpaca · SSR from Reg SHO 201
Wall Street consensusStrong Buy7 analysts
Avg target $10.29(+450% upside)
Range $3 – $15
6 buy0 hold1 sell

Analyst data via Nasdaq. Not investment advice.

Insiders

0 buys, 0 sells last 3 months (0/0 over 12 months)
Show 4 recent transactions
InsiderActionShares% of positionOwns afterValueDate
Tweardy Samuel David
Beneficial Owner (10%)
Sold (automatic/other)-631K
6.7% of company
sold 67%316Kn/aJul 7, 25
Wirk Shaheen
Director
Acquired (grant/award)+4K
0.04% of company
n/a4Kn/aApr 15, 25
Wirk Shaheen
Director
Acquired (grant/award)+439K
4.7% of company
n/a439Kn/aApr 15, 25
Hall Wallace L Jr
Director
Acquired (grant/award)+247K
2.6% of company
n/a247Kn/aApr 15, 25

Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.

$TVRD is down 6.5% today and has an active shelf on file. See who may be selling into moves →

Dilution watch

Active shelf

At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $TVRD runs, these filings show who may be positioned to sell new or newly-registered shares into the move.

Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.

$TVRD Sentiment

Bearish
Bearish18Bullish
📰 News: 1 bull · 3 bearToday: -6.5%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$TVRD Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

News· SEC EDGAR· 7d ago
Tvardi Therapeutics Selects Ulcerative Colitis
Alert· 9d ago +1.17%
$TVRD moved +1.17% in 1 min (Level 1) at 11:03 AM ET
at $2.58
Alert· 9d ago 38.9× RVOL
TVRD hit 38.869x RVOL at 11:03 AM ET
at $2.58
Alert· 15d ago -1.8% vs EMA
$TVRD near 200 EMA: -1.78% from 200 EMA at 1:53 PM ET
at $2.87
Alert· 15d ago 5.8× RVOL
TVRD hit 5.748x RVOL at 1:53 PM ET
at $2.87
Alert· 15d ago -1.77%
$TVRD moved -1.77% in 1 min (Level 1) at 1:53 PM ET
at $2.87
Alert· 15d ago -1.2% vs EMA
$TVRD near 200 EMA: -1.23% from 200 EMA at 12:00 PM ET
at $2.86
Alert· 15d ago 8.4× RVOL
TVRD hit 8.413x RVOL at 12:00 PM ET
at $2.86
Alert· 15d ago -1.40%
$TVRD moved -1.40% in 1 min (Level 1) at 11:58 AM ET
at $2.83
Alert· 16d ago +1.0% vs EMA
TVRD 50EMA (1m) Trending · 52 bars · L3 · +0.99% above EMA · slope +2.40%
at $3.03
Alert· 16d ago 2.0× RVOL
TVRD hit 2.000x RVOL at 1:15 PM ET
at $3.04
Alert· 16d ago 3.3× RVOL
TVRD hit 3.268x RVOL at 12:31 PM ET
at $3.04
Alert· 16d ago -1.3% vs EMA
$TVRD crossed below 200 EMA (-1.35% vs EMA) at 12:28 PM ET
at $2.90
Alert· 16d ago +2.84%
$TVRD moved +2.84% (~15m high-low range 2.84%) (Level 2) at 12:28 PM ET
at $2.90
Alert· 17d ago 3.8× RVOL
TVRD hit 3.824x RVOL at 9:36 AM ET
at $2.95
News· SEC EDGAR· 19d ago
Tvardi Therapeutics, Inc. filed an 8-K: Other Material Event
News· SEC EDGAR· 30d ago
Tvardi Therapeutics, Inc. filed an 8-K: Regulation FD Disclosure
News· SEC EDGAR· 55d ago
Tvardi Therapeutics, Inc. filed an 8-K: Shareholder Vote
News· GlobeNewswire Inc.· 177d ago Bullish
Idiopathic Pulmonary Fibrosis Clinical Trials & Pipeline Overview: Insights into 80+ Leading Companies and 100+ Novel Treatments | DelveInsight
News· GlobeNewswire Inc.· 224d ago Bearish
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
News· GlobeNewswire Inc.· 229d ago Bearish
SHAREHOLDER INVESTOR REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
News· GlobeNewswire Inc.· 250d ago Bearish
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics

Related PHARMACEUTICAL stocks

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

TVRD stock FAQ

Why is $TVRD down today?

Here is the latest on TVRD from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TVRD today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

What is the TVRD stock price today?

TVRD last traded at $1.87, down 6.54% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

When does TVRD report earnings?

Tvardi Therapeutics, Inc. Common Stock (TVRD) is next expected to report earnings on Thursday, August 13, 2026, about 7 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.

Where can I see live TVRD alerts?

The TVRD Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged TVRD 10 times in the last 30 days.

What exchange is TVRD on?

TVRD (Tvardi Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $19M in the PHARMACEUTICAL PREPARATIONS sector.

Is TVRD good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge TVRD for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.